3-hydroxyflavone has been researched along with HPV Infection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duerksen-Hughes, PJ; Filippova, M; Krstenansky, JL; Tungteakkhun, SS; Yuan, CH | 1 |
Duerksen-Hughes, PJ; Filippova, M; Krstenansky, JL; Yuan, CH | 1 |
2 other study(ies) available for 3-hydroxyflavone and HPV Infection
Article | Year |
---|---|
Small molecule inhibitors of the HPV16-E6 interaction with caspase 8.
Topics: Apoptosis; Caspase 8; Caspase Inhibitors; Fas-Associated Death Domain Protein; Female; Flavones; Flavonols; Host-Pathogen Interactions; Human papillomavirus 16; Humans; Oncogene Proteins, Viral; Papillomavirus Infections; Repressor Proteins; Small Molecule Libraries; Uterine Cervical Neoplasms | 2012 |
Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV⁺ cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Synergism; Flavonoids; Flavonols; Head and Neck Neoplasms; Humans; Imidazoles; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Pyridines; Repressor Proteins; Squamous Cell Carcinoma of Head and Neck; TNF-Related Apoptosis-Inducing Ligand | 2016 |